| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Detected and Quantified |
|---|
| Creation Date | 2017-12-11 17:01:58 UTC |
|---|
| Update Date | 2023-02-21 17:33:47 UTC |
|---|
| HMDB ID | HMDB0240253 |
|---|
| Secondary Accession Numbers | None |
|---|
| Metabolite Identification |
|---|
| Common Name | N-Acetyltaurine |
|---|
| Description | N-Acetyltaurine (also known as NAT) is a highly water-soluble and hygroscopic compound formed by the acetylation of taurine. It is both an endogenous metabolite that is constitutively synthesized in the body and an exogenous metabolite formed by ethanol metabolism. NAT is formed by one or multiple N-acetylation reactions between taurine and ethanol metabolites (primarily acetate). The enzyme responsible for NAT synthesis is called NAT synthase, a cytosolic metalloenzyme located in the kidney and liver that can directly catalyze the esterification reaction between taurine and acetate, without the involvement of ATP and CoA. NAT is a potential biomarker of hyperacetatemia as well as ethanol consumption (PMID: 22228769 ). NAT is typically found in human urine with normal concentrations of 0.599-1.38 umol/mmol creatinine in alcohol-abstinent subjects. NAT can reach average levels of 8.38 umol/mmol creatinine (range 5.39-10.47 umol/mmol creatinine) in subjects consuming alcohol within 3 to 6 h after the start of drinking. Positive NAT results can be used as an indicator for recent alcohol consumption (PMID: 27520321 ). NAT is considered a direct alcohol biomarker that specifically represents the oxidative pathway of ethanol metabolism. Other direct alcohol biomarkers such as fatty acid ethyl esters (FAEE), ethyl glucuronide, ethyl sulfate, and phosphatidylethanol reflect the non-oxidative pathway of alcohol metabolism. NAT is also elevated in urine after periods of endurance exercise. NAT was previously found in nature as a major component in the sticky droplet of orb spider web. Due to its high hygroscopicity, N-acetyltaurine appears to ensure the orb spider’s web flexibility. |
|---|
| Structure | InChI=1S/C4H9NO4S/c1-4(6)5-2-3-10(7,8)9/h2-3H2,1H3,(H,5,6)(H,7,8,9) |
|---|
| Synonyms | | Value | Source |
|---|
| 2-Acetamidoethanesulfonic acid | ChEBI | | 2-Acetamidoethanesulfonate | Generator | | 2-Acetamidoethanesulphonate | Generator | | 2-Acetamidoethanesulphonic acid | Generator | | NAT | HMDB | | Acetyltaurine | HMDB | | 2-(Acetylamino)ethanesulfonic acid | HMDB | | [2-Acetylamino]ethanesulfonic acid | HMDB | | Magnesium acetyltaurinate | HMDB | | ATaMg | HMDB | | Acetyltaurinate | HMDB | | Magnesium acetyltaurate | HMDB | | NAcT | HMDB | | N-Acetyltaurine | ChEBI |
|
|---|
| Chemical Formula | C4H9NO4S |
|---|
| Average Molecular Weight | 167.18 |
|---|
| Monoisotopic Molecular Weight | 167.025228948 |
|---|
| IUPAC Name | 2-acetamidoethane-1-sulfonic acid |
|---|
| Traditional Name | 2-acetamidoethanesulfonic acid |
|---|
| CAS Registry Number | 19213-70-8 |
|---|
| SMILES | CC(=O)NCCS(O)(=O)=O |
|---|
| InChI Identifier | InChI=1S/C4H9NO4S/c1-4(6)5-2-3-10(7,8)9/h2-3H2,1H3,(H,5,6)(H,7,8,9) |
|---|
| InChI Key | CXJAAWRLVGAKDV-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as organosulfonic acids. Organosulfonic acids are compounds containing the sulfonic acid group, which has the general structure RS(=O)2OH (R is not a hydrogen atom). |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organic acids and derivatives |
|---|
| Class | Organic sulfonic acids and derivatives |
|---|
| Sub Class | Organosulfonic acids and derivatives |
|---|
| Direct Parent | Organosulfonic acids |
|---|
| Alternative Parents | |
|---|
| Substituents | - Organosulfonic acid
- Sulfonyl
- Acetamide
- Alkanesulfonic acid
- Carboxamide group
- Secondary carboxylic acid amide
- Carboxylic acid derivative
- Carbonyl group
- Hydrocarbon derivative
- Organic oxide
- Organopnictogen compound
- Organosulfur compound
- Organooxygen compound
- Organonitrogen compound
- Organic oxygen compound
- Organic nitrogen compound
- Aliphatic acyclic compound
|
|---|
| Molecular Framework | Aliphatic acyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 3.02 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 8.6147 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 6.07 minutes | 32390414 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 910.9 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 293.2 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 64.0 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 176.4 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 55.1 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 239.4 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 243.3 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 657.7 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 574.2 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 51.5 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 775.0 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 186.0 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 176.3 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 535.3 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 245.5 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 228.8 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| N-Acetyltaurine,1TMS,isomer #1 | CC(=O)NCCS(=O)(=O)O[Si](C)(C)C | 1681.1 | Semi standard non polar | 33892256 | | N-Acetyltaurine,1TMS,isomer #1 | CC(=O)NCCS(=O)(=O)O[Si](C)(C)C | 1496.3 | Standard non polar | 33892256 | | N-Acetyltaurine,1TMS,isomer #1 | CC(=O)NCCS(=O)(=O)O[Si](C)(C)C | 2455.6 | Standard polar | 33892256 | | N-Acetyltaurine,1TMS,isomer #2 | CC(=O)N(CCS(=O)(=O)O)[Si](C)(C)C | 1636.1 | Semi standard non polar | 33892256 | | N-Acetyltaurine,1TMS,isomer #2 | CC(=O)N(CCS(=O)(=O)O)[Si](C)(C)C | 1594.0 | Standard non polar | 33892256 | | N-Acetyltaurine,1TMS,isomer #2 | CC(=O)N(CCS(=O)(=O)O)[Si](C)(C)C | 2730.7 | Standard polar | 33892256 | | N-Acetyltaurine,2TMS,isomer #1 | CC(=O)N(CCS(=O)(=O)O[Si](C)(C)C)[Si](C)(C)C | 1684.1 | Semi standard non polar | 33892256 | | N-Acetyltaurine,2TMS,isomer #1 | CC(=O)N(CCS(=O)(=O)O[Si](C)(C)C)[Si](C)(C)C | 1743.9 | Standard non polar | 33892256 | | N-Acetyltaurine,2TMS,isomer #1 | CC(=O)N(CCS(=O)(=O)O[Si](C)(C)C)[Si](C)(C)C | 2141.1 | Standard polar | 33892256 | | N-Acetyltaurine,1TBDMS,isomer #1 | CC(=O)NCCS(=O)(=O)O[Si](C)(C)C(C)(C)C | 1953.7 | Semi standard non polar | 33892256 | | N-Acetyltaurine,1TBDMS,isomer #1 | CC(=O)NCCS(=O)(=O)O[Si](C)(C)C(C)(C)C | 1781.8 | Standard non polar | 33892256 | | N-Acetyltaurine,1TBDMS,isomer #1 | CC(=O)NCCS(=O)(=O)O[Si](C)(C)C(C)(C)C | 2555.2 | Standard polar | 33892256 | | N-Acetyltaurine,1TBDMS,isomer #2 | CC(=O)N(CCS(=O)(=O)O)[Si](C)(C)C(C)(C)C | 1866.7 | Semi standard non polar | 33892256 | | N-Acetyltaurine,1TBDMS,isomer #2 | CC(=O)N(CCS(=O)(=O)O)[Si](C)(C)C(C)(C)C | 1873.5 | Standard non polar | 33892256 | | N-Acetyltaurine,1TBDMS,isomer #2 | CC(=O)N(CCS(=O)(=O)O)[Si](C)(C)C(C)(C)C | 2763.6 | Standard polar | 33892256 | | N-Acetyltaurine,2TBDMS,isomer #1 | CC(=O)N(CCS(=O)(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2162.7 | Semi standard non polar | 33892256 | | N-Acetyltaurine,2TBDMS,isomer #1 | CC(=O)N(CCS(=O)(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2296.9 | Standard non polar | 33892256 | | N-Acetyltaurine,2TBDMS,isomer #1 | CC(=O)N(CCS(=O)(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2286.5 | Standard polar | 33892256 |
|
|---|
| General References | - Shi X, Yao D, Chen C: Identification of N-acetyltaurine as a novel metabolite of ethanol through metabolomics-guided biochemical analysis. J Biol Chem. 2012 Feb 24;287(9):6336-49. doi: 10.1074/jbc.M111.312199. Epub 2012 Jan 6. [PubMed:22228769 ]
- Luginbuhl M, Rutjens S, Konig S, Furrer J, Weinmann W: N-Acetyltaurine as a novel urinary ethanol marker in a drinking study. Anal Bioanal Chem. 2016 Oct;408(26):7529-36. doi: 10.1007/s00216-016-9855-7. Epub 2016 Aug 13. [PubMed:27520321 ]
- Elshenawy S, Pinney SE, Stuart T, Doulias PT, Zura G, Parry S, Elovitz MA, Bennett MJ, Bansal A, Strauss JF 3rd, Ischiropoulos H, Simmons RA: The Metabolomic Signature of the Placenta in Spontaneous Preterm Birth. Int J Mol Sci. 2020 Feb 4;21(3). pii: ijms21031043. doi: 10.3390/ijms21031043. [PubMed:32033212 ]
|
|---|